DL-Allylglycine
Product Specifications
UNSPSC Description
DL-Allylglycine (2-Aminopent-4-enoic acid) is a glutamate decarboxylase (GAD) inhibitor. DL-Allylglycine has convulsant activity that can be used in studies to induce epileptic seizures[1][2].
Target Antigen
Amino Acid Derivatives
Type
Peptides
Related Pathways
Others
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/dl-allylglycine.html
Purity
98.0
Solubility
H2O : 5.56 mg/mL (ultrasonic)
Smiles
C=CCC(N)C(O)=O
Molecular Weight
115.132
References & Citations
[1]Castellano C, et al. Effects of DL-allylglycine, alone or in combination with morphine, on passive avoidance behaviour in C57BL/6 mice. Arch Int Pharmacodyn Ther. 1984 Jan;267(1):141-8. |[2]Meldrum BS, et al. Proconvulsant, convulsant and other actions of the D- and L-stereoisomers of allylglycine in the photosensitive baboon, Papio papio. Electroencephalogr Clin Neurophysiol. 1979 Oct;47(4):383-95.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-W023493/DL-Allylglycine-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-W023493/DL-Allylglycine-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
7685-44-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
